Renal and Vascular Phenotypic Characterization of Patients With Enamel Renal Syndrome Due to a Pathogenic Variant of the FAM20A Gene and Pathophysiological Study of Ectopic Calcifications

NCT07285421 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-12-16

No results posted yet for this study

Summary

In the research, the investigators will characterize the renal and vascular damage and look for factors favoring the formation of calcification induced by enamel renal syndrome.

Patients will undergo four investigations, as part of their routine care, to assess their renal impairment. Each investigation will require a day in the Physiology Department of the George Pompidou European Hospital.

The 4 tests are designed to

* precisely measure your renal filtration capacity,
* evaluate your body's calcium and phosphate regulation,
* evaluate your capacity to regulate the elimination of water from the body
* assess your body's ability to regulate "acid" intake. As part of the research, an additional 20 ml blood sample and a urine sample will be taken during the other samples taken as part of routine care.

Healthy volunteers will undergo blood and urine tests, dental X-rays and renal ultrasound. For healthy volunteers, the aim of the dental X-ray and renal ultrasound is to check that there are no dental or renal abnormalities, so as to rule out not only email-rein syndrome, but also any dental or renal abnormalities that might resemble it. The aim of blood and urine sampling is to measure various molecules that promote calcification or inhibit the calcification process, so as to be able to compare results obtained in healthy subjects with those obtained in patients with enamel renal syndrome. Each healthy subject will be selected to be matched by age and sex to each of the patients included in the study.

Conditions

  • Enamel Renal Syndrome

Interventions

DIAGNOSTIC_TEST

urinary proteome

Volume 2 ml, with protease inhibitor made one time for each arm of the protocol

DIAGNOSTIC_TEST

urinary metabolome

Sample collected once in the protocol for each arm.

DIAGNOSTIC_TEST

Evaluation of plasma mineralization factors

Complementary plasma analysis during another blood sample collection for both arms

DIAGNOSTIC_TEST

Renal ultrasound

Verification of normal renal morphology, absence of nephrocalcinosis

RADIATION

dental panoramic x-ray

Verification of normal dentition

BIOLOGICAL

Blood and urine minimal biology

Fasting blood: creatinine, blood ions (Na + K + Cl + CO2 + Proteins), calcium, phosphate, CBC (Complete Blood Count), liver function tests, lipid profile); Morning fasting urine: creatinine, calcium, phosphate, protein, urinalysis (ECBU)

Sponsors & Collaborators

  • Fondation Université de Paris

    collaborator UNKNOWN
  • Université de Liège

    collaborator OTHER
  • Institut Necker Enfants Malades

    collaborator OTHER
  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2029-10-30
Completion
2029-10-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07285421 on ClinicalTrials.gov